August 2, 2010

CASE CCC IN THE NEWS

Dendreon's Prostate Cancer Drug Extends Life in Published Study
BusinessWeek - Jul 28, 2010
"By the time the data was presented to the FDA, this was a pretty mature trial," said Robert Dreicer, chair of solid tumor oncology at the Cleveland Clinic ...

Breast Cancer Drug: Do Risks Outweigh Benefits?
ABC News - Jul 20, 2010
UH Case Medical Center's Dr. Paula Silverman discusses Avastin in breast cancer.

Cleveland Clinic Uses New Prostate Cancer Screening Test
Plain Dealer - Jul 20, 2010
"A few centers around the country, including us, are doing it routinely now [for those patients]," said Dr. Eric Klein, chairman of the Glickman Urological and Kidney Institute at the Clinic...

Low Fat Diet May Keep Prostate Cancer Away
Worlds Breaking News - Jul 14, 2010
Contained in a recently released study, Dr. Sanjay Gupta and other medical professionals proved that NF-kB is released, after the prolonged consumption of ...

NCI CANCER BULLETIN

Featured Article
FDA Advisory Committee Recommends against Bevacizumab for Metastatic Breast Cancer

Cancer Research Highlights
PSA Screening Leads to Aggressive Treatment, Even in Older Men at Low Risk

Chemotherapy Regimen Benefits Men with Metastatic Penile Cancer

Hormone Therapy Increases Breast Cancer Risk for Women with Dense Breasts

Brain Cancer Incidence Trends Do Not Support Link to Cell Phones

Expert Panel Reports on Knowledge Gaps for 20 Suspected Carcinogens

Special Report
The Evolving Science of Cancer Stem Cells

ANNOUNCEMENTS

Message from Dr. Noa Noy: Cancer Pharmacology Training Grant Update

The steering committee of the Cancer Pharmacology training grant met on July 7. The discussion focused on the selection of one post doctoral and one predoctoral trainee, and admission of additional trainers.

I am happy to report that the applicant pool was very strong and required much deliberation. Two post doctoral applicants were ranked equally and I subsequently interviewed both of them. We will be appointing Edward Motea (laboratories of Tony Berdis and Irene Lee) to the predoctoral slot, and Nic Salem (laboratories of Jim Basilion and Ruth Keri) to the post doctoral slot. Additional slots will become available next year.

In addition, applications to join the trainer list by Tatiana Byzova and Barbara Bedogni, in the area of Cancer biology, and by Ray Muzic, in the area of Imaging, have been approved.

NEW FUNDING OPPORTUNITIES

Request for Proposals: Basic, Clinical, or Translational Human Tissue Based Cancer Research Projects

The Case CCC will provide seed money to foster collaborations and to promote and increase institution-wide capacity and competitiveness in basic, clinical or translational human tissue based research.

Three awards of $50,000 and three awards at $20,000 apiece will be awarded to investigators who intend to gather preliminary data to be used in seeking future independently funded programs and support.

Case CCC members with a faculty appointment at all levels (eligible to apply for independent nationally competitive research grants) are encouraged to apply. Proposals from both junior and senior investigators are encouraged. Postdoctoral fellows, graduate students and research associates are not eligible to apply for these pilot grants. It is expected that these grants will represent collaborative efforts between lab based or quantitative science-based and clinical investigators, likely a clinician who is a member of the disease team of the tissue research in question.

Deadline: September 10

Details are available on the cancer center website.

CTSC Pilot Funding Competition

The CTSC is accepting applications for core utilization pilot funding of up to $10,000 to support activities provided by any of the CTSC Core facilities.
CWRU, UH and Metro Deadline: August 1
Cleveland Clinic Deadline: August 9

Leukemia and Lymphoma Society

The Leukemia and Lymphoma Society is accepting applications for the following funding opportunities. All awards have a required LOI Deadline of September 15.

• Scholars are highly qualified investigators who have shown a capacity for independent, sustained original investigation in the field of leukemia, lymphoma, and myeloma. These Scholars are expected to hold independent faculty-level or equivalent positions and have obtained substantial support for their research from a national agency.
• Scholars in Clinical Research are highly qualified investigators who are expected to hold independent faculty-level appointments and who are conducting original, independent applied research, often involving early-stage clinical trials which will advance the prevention, diagnosis or treatment of hematologic malignancies. These Scholars are expected to have concomitant support for their research from another source or agency.
• Special Fellows are qualified investigators who have completed a minimum of two years of postdoctoral research training and are continuing their research under the direction of a research Sponsor. The Special Fellowship should permit the scientist to begin to transition to an independent research program.
• Special Fellows in Clinical Research (SFCR) are researchers who hold an MD, PhD or equivalent degree and have completed a minimum of two years of clinical hematology, oncology, hematology/oncology or hematopathology training or postdoctoral research training in a clinical discipline (e.g., cytogenetics, molecular pathology). These grantees should provide evidence that their career focus will be on the prevention, diagnosis, or treatment of leukemia, lymphoma, or myeloma.
• Fellows are promising investigators with less than two years of postdoctoral research training. These grantees are encouraged to embark on an academic career involving clinical or fundamental research in, or related to, leukemia, lymphoma or myeloma under the direction of a research sponsor.

MARK YOUR CALENDARS

Case CCC Scientific Series: Basic Science of Cancer Focus Group Pilot Projects

Come and hear updates on the Basic Science of Cancer Group pilot projects at the next Case CCC Scientific Series, August 30 from 4-7 pm in Wolstein Auditorium (WRB 1413). Details to follow.

EVENTS

**All events are open to anyone interested in attending

August 2

Special Seminar: Breast Program Candidate
Edgardo Rivera, MD
Associate Professor- Medicine
Medical Director TMH Breast Cancer
Chief, Breast Medical Oncology Section
Methodist Hospital/Weill Cornell University
Topic: Treatment Options for Metastatic Breast Cancer: Goals of Therapy & Patient Considerations
12 pm WRB 2-136

Taussig Cancer Institute Core Curriculum Series
Robert Dreicer, MD
Professor, Hematology & Medical Oncology
CWRU/ Cleveland Clinic
Topic: Hormonal and Chemotherapy for Prostate Cancer
12 pm R3-002 Cleveland Clinic

Tumor Signaling Metastasis Meeting
2 pm WRB 3-136

August 3

Taussig Cancer Institute Core Curriculum Series
John Sweetenham, MD
Professor, Hematologic Oncology & Blood Disorders
CWRU/ Cleveland Clinic
Topic: Aggressive Non-Hodgkin Lymphoma
12 pm R3-002 Cleveland Clinic

August 4

ICC Grand Rounds
Charles Kunos, MD
Director, Gynecologic and Pediatric Radiation Oncology
CWRU/ UH
Topic: Principles of Radiation Oncology
8 am Lerner Tower B-151

August 5

Taussig Cancer Institute Core Curriculum
Robert Pelley, MD
Staff, Solid Tumor Oncology
Cleveland Clinic
Topic: Overview of Colon Cancer
12 pm R3-002 Cleveland Clinic

August 6

Taussig Cancer Institute Grand Rounds will resume September 10

Cancer Center Research in Progress Seminar will resume in September

Hematology and Oncology Fellows
Lisa Arfons, MD
Assistant Professor, Medicine- Hem/Onc
CWRU/ UH
Topic: Anemia and Approach to Red Cell Disorders
8 am Wearn 137

Case CCC Calendar

LRI Calendar

UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS

Cancer Center Scientific Series
August 30
4-7 pm WRB 1-413

Cancer Center Scientific Series
November 8
4-7 pm WRB 1-413

ADDITIONAL UPCOMING SEMINARS & EVENTS

Third Annual Golf Skills Clinic for Kids Kicking Cancer
August 2
Washington Golf Learning Center, Newburgh Heights, OH
Details

Clinical Proteomic Technologies for Cancer (CPTC) 2010 Annual Meeting
September 8-9
Bethesda North Marriott Hotel & Conference Center, MD
Details

2010 caBIG Annual Meeting: Building a Collaborative Biomedical Network
September 13-15
Washington, DC
Details

Oncology Congress
October 15-17
San Francisco, CA
Details

2010 Cleveland Nanomedicine Summit
October 18-19
InterContinental Hotel, Cleveland, OH
Clinical and research abstracts will be accepted through September 3
Details

International Symposium on Breast Cancer Prevention: Nutrition, Communication and Public Policy
October 18-19
Purdue University, West Lafayette, IN
Details

ASCO-NCI-EORTC Annual Meeting on Molecular Markers in Cancer
October 18-20
Hollywood, FL
Call for Abstracts

Graft versus Host Disease Conference
November 4
Corporate College East, Cleveland, OH
Details

Active Living Research Annual Conference
February 22-24, 2011
San Diego, CA
Call for Abstracts Deadline: August 6
Details

PREVIOUSLY ANNOUNCED FUNDING OPPORTUNITIES

Alex's Lemonade Stand Foundation 'A' Award
Deadline: August 2

Alex's Lemonade Stand Foundation Nursing Grant Program
Deadline: August 2

DOD PRMRP Investigator-Initiated Research Award
Application Deadline: August 5

Susan G. Komen for the Cure Promise Grants
Pre Application Deadline: extended to August 10
Full Application Deadline: December 7

AACR-Genentech BioOncology Career Development Award for Cancer Research on the HER Family Pathway
Deadline: August 10

AACR Judah Folkman Fellowship for Angiogenesis Research
Deadline: August 10

Mesothelioma Applied Research Foundation
Deadline: August 11

Active Living Research Translating Research to Policy Award
Deadline: August 25

Avon Foundation for Women Breast Health Outreach Program
Deadline: August 27

Induced Pluripotent Stem Cell Pilot Research Award
Application Deadline: extended to August 31

IOTF Cancer Prevention Fellows
Application Deadline: September 1

ASCO Cancer Foundation Improving Cancer Care Grant, funded by Susan G. Komen for the Cure
Required LOI Deadline: September 1

Raymond and Beverly Sackler AACR Fellowships for Ileal Carcinoid Tumor Research
Deadline: September 15

Caring for Carcinoid Foundation–AACR Grants for Carcinoid Tumor and Pancreatic Neuroendocrine Tumor Research
September 15

DOD Peer Reviewed Cancer Research Program (PRCRP) Concept Award
Pre-Application Deadline: September 15
Application Deadline: September 29

William Lawrence & Blanche Hughes Foundation
Deadline: September 16

DOD Peer Reviewed Cancer Research Program (PRCRP) Concept Award
Application Deadline: September 29

DOD Peer Reviewed Cancer Research Program (PRCRP) Idea Awards
Application Deadline: October 20

DOD Peer Reviewed Cancer Research Program (PRCRP) Translational New Investigator Awards
Application Deadline: October 20

Susan G. Komen for the Cure Investigator-Initiated Research (IIR)
Full Application Deadline: November 2

Susan G. Komen for the Cure Career Catalyst Research (CCR) Grants
Full Application Deadline: November 2

Susan G. Komen for the Cure Promise Grants
Full Application Deadline: December 7

AACR Scholar-in-Training Awards - Special Conferences
Application Deadline varies

International Union Against Cancer (UICC) International Cancer Technology Transfer Fellowships
Application Deadline: Open

NCI Short-Term Scientist Exchange Program
Application Deadline: Open

James S. McDonnell Foundation
Application Deadline: Open

NIH BULLETIN – Notices and Funding Opportunities

Animal Welfare and Scientific Research: 1985 to 2010 Symposium plus IACUC 101 & AWIC Workshops (NOT-OD-10-119)

Clarification of Application Page Limits for PAR-09-157: In vivo Cellular and Molecular Imaging Centers (ICMICs)(P50) (NOT-CA-10-033)

Nutrition and Alcohol-Related Health Outcomes (R01) (PA-10-239)

HELP US HELP YOU!

If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!

Send items to gillian.irwin@case.edu.